Related Experiment Video
Updated: Jul 28, 2026

Cell-Free DNA Integrity Analysis in Urine Samples
Published on: January 5, 2017
Satellite DNA Amplification in Advanced Prostate Cancer Is Largely Independent From Euchromatic and Oncogene
Anja Weise1, Antonio Augusto Ornellas2, Gilda Alves3
1Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Jena, Germany.
Abstract:
Recently, we were able to show that satellite DNA amplification (satDNA-AMP) is present in advanced prostate cancer. A chromosome microarray study provided first evidence that satDNA-AMP appears to be largely independent of centromere-near/pericentric euchromatic copy number alterations. Therefore, it might be carefully suggested that satDNA-AMP could be a new and independent marker for advanced tumor progression.
Insights
Satellite DNA amplification (satDNA-AMP) is found in advanced prostate cancer. This finding suggests satDNA-AMP may serve as a novel marker for tumor progression, independent of other genetic changes.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Advanced prostate cancer is a complex disease with various genetic alterations.
- Satellite DNA (satDNA) amplification has recently been observed in advanced prostate cancer.
- Understanding novel biomarkers is crucial for tracking tumor progression.
Purpose of the Study:
- To investigate the presence and characteristics of satellite DNA amplification (satDNA-AMP) in advanced prostate cancer.
- To determine if satDNA-AMP is an independent marker of tumor progression.
Main Methods:
- Utilized chromosome microarray analysis to study copy number alterations.
- Focused on satellite DNA amplification in advanced prostate cancer samples.
Main Results:
- Satellite DNA amplification (satDNA-AMP) was confirmed in advanced prostate cancer.
- Evidence suggests satDNA-AMP is largely independent of copy number alterations near centromeres.
Conclusions:
- Satellite DNA amplification (satDNA-AMP) is a potential new biomarker for advanced prostate cancer.
- satDNA-AMP may indicate tumor progression independently of other genetic changes.

